Human medicines European public assessment report (EPAR): Firdapse (previously Zenas), amifampridine, Date of authorisation: 23/12/2009, Revision: 22, Status: Authorised

Keppra

A common EU approach to data transparency in medicine regulation

Heads of Medicines Agencies / European Medicines Agency guidance document on the identification of commercially confidential information and personal data within the structure of the marketing-authorisation application: ...

Call for expression of interest for Academia to participate in the European Platform for Regulatory Science Research

Human medicines European public assessment report (EPAR): Signifor, pasireotide, Date of authorisation: 24/04/2012, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Wilzin, zinc, Date of authorisation: 12/10/2004, Revision: 12, Status: Authorised

Innovation Task Force (ITF) briefing meeting request form

UPD refresher webinar for marketing authorisation holders on volume of sales submission, Online, from 5 December 2024, 10:00 (CET) to 5 December 2024, 11:00 (CET)

Minutes of the CHMP meeting 22-25 July 2024